SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-287589
Filing Date
2015-08-12
Accepted
2015-08-12 11:34:14
Documents
13
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-K d907829d10k.htm 10-K 1117388
2 EX-21.1 d907829dex211.htm EX-21.1 9374
3 EX-23.1 d907829dex231.htm EX-23.1 3420
4 EX-31.1 d907829dex311.htm EX-31.1 8275
5 EX-31.2 d907829dex312.htm EX-31.2 8263
6 EX-32 d907829dex32.htm EX-32 3871
13 GRAPHIC g907829image001.jpg GRAPHIC 43660
  Complete submission text file 0001193125-15-287589.txt   7962743

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mygn-20150630.xml EX-101.INS 1545056
8 XBRL TAXONOMY EXTENSION SCHEMA mygn-20150630.xsd EX-101.SCH 86623
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20150630_cal.xml EX-101.CAL 140098
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20150630_def.xml EX-101.DEF 544766
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20150630_lab.xml EX-101.LAB 695100
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20150630_pre.xml EX-101.PRE 644343
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26642 | Film No.: 151046027
SIC: 2835 In Vitro & In Vivo Diagnostic Substances